Three emerging new drugs for NSCLC: Pemetrexed, bortezomib, and cetuximab

Sarita Dubey, Joan H. Schiller

Research output: Contribution to journalArticlepeer-review

38 Scopus citations

Fingerprint

Dive into the research topics of 'Three emerging new drugs for NSCLC: Pemetrexed, bortezomib, and cetuximab'. Together they form a unique fingerprint.

Medicine & Life Sciences